29.01.2016
- Time is money; this holds particularly true for drug research and development. The global pharmaceutical industry spends about $100 billion a year on R&D. Researchers are...
01.10.2013
- Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...
